Results 261 to 270 of about 884,783 (299)

Person-level health factors partially mediate the association between lesbian, gay, or bisexual (LGB) identity, allostatic load, and cancer mortality in NHANES. [PDF]

Cancer Causes Control
Moore JX, Patel A, Spears M, Casanova T, Weiss HL, Langston ME, Watts KJ, Boyd D, Adsul P, Duncan M, Howard S.   +10 more
europepmc   +1 more source

Single-dose HPV vaccination in the United States - a multi-modeling analysis. [PDF]

Lancet Reg Health Am
Burger EA, Laprise JF, Spencer JC, Sy S, Regan MC, Drolet M, Chamberland É, Brisson M, Kim JJ.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Price variability of pembrolizumab across U.S. National Cancer Institute–designated Cancer Centers (NCICCs) from 2016-2021.

Journal of Clinical Oncology, 2022
48 Background: NCICCs are poorly compliant to price transparency rules set forth by the CMS. Competitive price shopping is prevented due to a lack of uniform rate setting, and service charges are often higher than what a hospital reasonably expects to be reimbursed.
S. M. Qasim Hussaini, Jordan Johnson, Fumiko Chino   +2 more
openaire   +1 more source

Analysis of demographic characteristics and disparities of enrollment in cancer clinical research at the U.S. National Cancer Institute (NCI): A 15-year experience.

Journal of Clinical Oncology, 2022
6529 Background: Racial, gender, and socioeconomic disparities in cancer clinical trials participation have been well documented. The intramural program of the NCI in the National Institutes of Health (NIH) Bethesda campus conducts clinical research where participants are referred by their physician or self-referred, treated without charge and ...
Nirmal Choradia, James L. Gulley, Charalampos S. Floudas   +2 more
openaire   +1 more source

Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's drug discovery program for cancer and AIDS

STEM CELLS, 1994
The National Cancer Institute's drug discovery program screens more than 20,000 chemical compounds and natural products a year for activity against a panel of 60 tumor cell lines in vitro. The result is an information-rich database of patterns that form the basis for what we term an "information-intensive" approach to the process of drug discovery. The
J. N. Weinstein, T. Myers, J. Buolamwini, K. Raghavan, W. Van Osdol, J. Licht, V. N. Viswanadhan, K. W. Kohn, L. V. Rubinstein, A. D. Koutsoukos, A. Monks, D. A. Scudiero, D. Zaharevitz, B. A. Chabner, N. L. Anderson, M. R. Grever, K. D. Paull   +16 more
openaire   +2 more sources

The expanding role of cancer control & the U.S. National Cancer Institute: Policy implications for global cancer care

Journal of Cancer Policy, 2019
Abstract Throughout the global community, cancer control has been recognized as an important component of cancer care for populations, patients and their families. The United States had a pioneering effort, created as a result of the 1971 National Cancer Act (The War on Cancer), when it mandated that the National Cancer Institute (NCI), in ...
Arnold D. Kaluzny, Donna M. O’Brien
openaire   +1 more source

Chemoprevention Research at the U.S. National Cancer Institute

Military Medicine, 1994
The use of specific chemicals to prevent the development or retard the progression of carcinogenesis--known as chemoprevention--is a rapidly growing area in cancer research. Developed through the integration of strong laboratory and epidemiologic evidence, chemoprevention research has moved successfully into the clinical research setting, with diverse ...
openaire   +2 more sources

Global cancer stigma research: a U.S. National Cancer Institute workshop report

JNCI Monographs
Abstract Stigma is a social process characterized by negative beliefs, attitudes, and stereotypes associated with a specific attribute or characteristic that leads to discrimination and social exclusion. Stigma manifests across the cancer control continuum and remains a key challenge for cancer prevention and control worldwide.
Kathryn Heley, Robin C Vanderpool, Vidya Vedham   +2 more
openaire   +2 more sources

Information resources for liposome research: The drug discovery program of the u.s. national cancer institute

Journal of Liposome Research, 1995
Between April 1990 and June 1995, the National Cancer Institute (NCI) has screened 46,598 chemical compounds for activity against 60 human cancer cell lines from different organs. The resulting database of activity profiles is complemented by a second database containing 2-D and 3-D structural descriptors of those compounds, along with structural ...
J. N. Weinstein, T. G. Myers
openaire   +1 more source